Biotechnological application of Aureobasidium spp. as a promising chassis for biosynthesis of ornithine-urea cycle-derived bioproducts

• Published in: Critical reviews in biotechnology 2024-08, p.1
• Main Authors: Myo Myo Tint, Khin, Wei, Xin, Wang, Peng, Liu, Guang-Lei, Zhang, Mei, Chi, Zhen-Ming, Chi, Zhe
• Format: Article
• Language: English
• ISSN: 1549-7801; 1549-7801
• DOI: 10.1080/07388551.2024.2382954

The ornithine-urea cycle (OUC) in fungal cells has biotechnological importance and many physiological functions and is closely related to the acetyl glutamate cycle (AGC). Fumarate can be released from argininosuccinate under the catalysis of argininosuccinate lyase in OUC which is regulated by the Ca signaling pathway and over 93.9 ± 0.8 g/L fumarate can be yielded by the engineered strain of var. i in the presence of CaCO . Furthermore, 2.1 ± 0.02 mg of L-ornithine (L-Orn)/mg of the protein also can be synthesized OUC by the engineered strains of . Fumarate can be transformed into many drugs and amino acids and L-Orn can be converted into siderophores (1.7 g/L), putrescine (33.4 g/L) and L-piperazic acid (L-Piz) (3.0 g/L), by different recombinant strains of . All the fumarate, L-Orn, siderophore, putrescine and L-Piz have many applications. As the yeast-like fungi and the promising chassis, spp, have many advantages over any other fungal strains. Further genetic manipulation and bioengineering will enhance the biosynthesis of fumarate and L-Orn and their derivates.